Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Bünde – page 9

618 clinical trials in Bünde, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Bünde at a glance
618
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

618 trials in Bünde

Open in trial search

A Study of JNJ-78278343 Compared to Placebo for Patients with Advanced Prostate Cancer That No Longer Responds to Hormone Treatment

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:JNJ-78278343
  • Sponsor:Janssen Cilag International

A Study to Test How Well PKN605 Works and How Safe It Is in Patients with Atrial Fibrillation

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:PKN605
  • Sponsor:Novartis Pharma AG

Study of gemcitabine, cisplatin, and pembrolizumab before and after surgery compared to surgery alone for patients with bile duct cancer

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Amsterdam UMC Stichting

A Study of MK-1084 and Drug Combination Versus Pembrolizumab and Chemotherapy for Adults with Advanced Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Testing dapagliflozin to slow kidney function decline in patients with autosomal dominant polycystic kidney disease

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Dapagliflozin
  • Sponsor:University Of Cologne

A study to test the safety and effectiveness of BAY 3713372 alone and with drug combination in patients with MTAP-deleted solid tumors

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:BAY 3713372
  • Sponsor:Bayer AG

Prostate cancer

Recruiting

Study of xaluritamig plus abiraterone for men with metastatic castration-resistant prostate cancer who have not received chemotherapy

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:Amgen Inc.

Phenylketonuria

Recruiting

A Study of Repinatrabit Compared to Placebo for Treatment of Patients with Phenylketonuria

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Repinatrabit
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Testing Cabozantinib Dose Skipping Schedule Compared to Dose Reduction in Patients with Kidney Cancer Taking Cabozantinib Treatment

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Cabozantinib
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)

Study of Different Dosing Schedules of Osimertinib in Patients with EGFR Mutated Advanced or Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Osimertinib
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Study of daratumumab, teclistamab and talquetamab combination treatment for frail patients with newly diagnosed multiple myeloma

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Emn Trial Office S.r.l. Impresa Sociale

Study of alteplase and tenecteplase for intravenous thrombolysis in patients with ischemic stroke who are taking direct oral anticoagulants

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:Insel Gruppe AG

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Bünde

What the registry says about research in the country

01 Nutritional and Metabolic Diseases

The clinical trial activity in Bünde is centered on Nutritional and Metabolic Diseases, with studies focused on improving care for obesity, overweight, and type 2 diabetes. These trials are mainly testing new treatment approaches and assessing how well they support weight management and blood sugar control.

  • Weight-related treatment studies in obesity and overweight
  • Type 2 diabetes research aimed at better glycaemic control
  • Trials exploring therapy effectiveness in people with combined metabolic conditions
  • Clinical research designed to improve everyday treatment options

Several studies also connect metabolic health with other conditions, showing a broad interest in practical treatment strategies for patients in routine care.

02 Kidney Disease Research

One important area of research in Bünde involves chronic kidney disease, with trials examining whether new treatment combinations can help preserve kidney function. The goal is to evaluate treatment effectiveness and support better long-term kidney health.

  • Chronic kidney disease as a key focus of ongoing research
  • Studies assessing kidney function outcomes
  • Testing new therapeutic combinations for improved disease control

This work reflects a strong interest in finding more effective options for people living with progressive kidney problems.

03 Obesity and Weight Management

Clinical trials in the area of obesity and overweight are exploring whether new therapies can support meaningful body weight reduction. These studies are aimed at evaluating treatment benefit in people who need better options for long-term weight control.

  • Obesity and overweight as main conditions under study
  • Research focused on weight change and treatment response
  • Testing new approaches for healthier metabolic outcomes

The trials address an important area of public health by looking for more effective ways to manage excess weight.

04 Metabolic Disease and Diabetes Care

Another major theme is type 2 diabetes management, where trials are comparing treatment approaches to see how well they maintain blood sugar levels in real-world practice. The emphasis is on improving treatment effectiveness for people who already use glucose-lowering medication.

  • Type 2 diabetes treatment optimization
  • Comparisons of longer-acting and daily insulin-based options
  • Focus on sustained blood sugar control over time

These studies may help shape more practical and patient-friendly diabetes care strategies.

05 Osteoarthritis and Joint Pain

Research also includes osteoarthritis, especially knee pain linked with obesity or overweight. The trials are looking at ways to ease joint symptoms while also supporting weight-related health goals.

  • Osteoarthritis with a focus on knee pain
  • Studies involving people with obesity or overweight
  • Evaluation of symptom relief and functional improvement

This area connects musculoskeletal care with metabolic health, reflecting the close relationship between body weight and joint discomfort.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.